Seroprevalence of hepatitis C virus in Jinan, China, 2008-2020.

ABSTRACT:

Background

The updated estimates of hepatitis C virus (HCV) seroprevalence are critical for developing strategies to manage or eliminate HCV infection.

Methods

A comprehensive study on HCV seroprevalence was conducted among 365,210 patients at Jinan Central Hospital, China, from 2008 to 2020. The patients were tested for anti-HCV, HCV core antigen, hepatitis B surface antigen, syphilis antibody, human immunodeficiency virus antigen + antibody, antihepatitis A virus IgM, and antihepatitis E virus IgM.

Results

HCV seroprevalence was 0.79% and was related to age. HCV seropositivity was lower in children (aged  < 18 years) than in adults (aged  ≥ 18 years) (0.15% vs. 0.81%). High HCV prevalence was reported in adults aged  ≥ 41 years, and HCV seropositivity in those aged

SUBMITTER: Xu M 

PROVIDER: S-EPMC9997000 | biostudies-literature | 2023 Mar

REPOSITORIES: biostudies-literature